联系客服

301267 深市 华厦眼科


首页 公告 华厦眼科:2023年半年度报告摘要

华厦眼科:2023年半年度报告摘要

公告日期:2023-08-30

华厦眼科:2023年半年度报告摘要 PDF查看PDF原文

证券代码:301267      证券简称:华厦眼科      公告编号:2023-027

      华厦眼科医院集团股份有限公司

          2023 年半年度报告摘要

                  2023 年 8 月

一、重要提示
本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规划,投资者应当到证监
会指定媒体仔细阅读半年度报告全文。
所有董事均已出席了审议本报告的董事会会议。
非标准审计意见提示
□适用 不适用
董事会审议的报告期普通股利润分配预案或公积金转增股本预案
□适用 不适用
公司计划不派发现金红利,不送红股,不以公积金转增股本。
董事会决议通过的本报告期优先股利润分配预案
□适用 不适用
二、公司基本情况
1、公司简介

 股票简称                          华厦眼科              股票代码              301267

 股票上市交易所                    深圳证券交易所

        联系人和联系方式                      董事会秘书                        证券事务代表

 姓名                              曹乃恩                            沈石华

 电话                              0592-2108975                        0592-2108975

 办公地址                          厦门市湖里区五通西路 999 号        厦门市湖里区五通西路 999 号

 电子信箱                          zhengquanbu@huaxiaeye.com          zhengquanbu@huaxiaeye.com

2、主要会计数据和财务指标
公司是否需追溯调整或重述以前年度会计数据
□是 否

                                                                                      本报告期比上年同期
                                              本报告期              上年同期

                                                                                              增减


    营业收入(元)                                1,993,689,033.80      1,578,567,959.77              26.30%

    归属于上市公司股东的净利润(元)                354,706,803.55        236,338,945.33              50.08%

    归属于上市公司股东的扣除非经常性损益

    的净利润(元)                                  362,770,536.46        256,814,041.73              41.26%

    经营活动产生的现金流量净额(元)                436,912,869.58        409,182,249.40                6.78%

    基本每股收益(元/股)                                    0.63                0.47              34.04%

    稀释每股收益(元/股)                                    0.63                0.47              34.04%

    加权平均净资产收益率                                    6.74%              12.12%              -5.38%

                                                                                          本报告期末比上年度

                                                  本报告期末              上年度末

                                                                                                末增减

    总资产(元)                                  7,095,499,169.28      6,584,482,315.79                7.76%

    归属于上市公司股东的净资产(元)              5,306,894,838.13      5,114,136,775.46                3.77%

  3、公司股东数量及持股情况

                                                                                                    单位:股

                                                          报告期末表决

                                                                                            持有特别表决

                                                          权恢复的优先

报告期末普通股股东总数                              11,355                                0  权股份的股东        0
                                                          股股东总数

                                                                                            总数(如有)

                                                          (如有)

                                              前 10 名股东持股情况

                                                                            持有有限售条件  质押、标记或冻结情况
          股东名称              股东性质      持股比例      持股数量

                                                                              的股份数量      股份状态    数量

华厦医疗投资(厦门)有限公司  境内非国有法人      30.45%    170,509,341      170,509,341

苏庆灿                          境内自然人        30.41%    170,270,659      170,270,659

厦门涵蔚股权投资合伙企业(有

                              境内非国有法人      5.44%      30,487,500        30,487,500

限合伙)
北京磐茂投资管理有限公司-磐

茂(上海)投资中心(有限合        其他            4.38%      24,500,000        24,500,000

伙)
启鹭(厦门)股权投资合伙企业

                              境内非国有法人      4.02%      22,500,000        22,500,000

(有限合伙)
厦门鸿浮股权投资合伙企业(有

                              境内非国有法人      3.90%      21,830,000        21,830,000

限合伙)

厦门昊蕴股权投资合伙企业(有  境内非国有法人      3.46%      19,389,500        19,389,500

限合伙)
厦门禄凯股权投资合伙企业(有

                              境内非国有法人      2.71%      15,181,000        15,181,000

限合伙)
厦门博凯股权投资合伙企业(有

                              境内非国有法人      2.07%      11,612,000        11,612,000

限合伙)
厦门颂胜股权投资合伙企业(有

                              境内非国有法人      1.54%      8,600,000        8,600,000

限合伙)

                                              苏庆灿系公司的实际控制人,其直接持有公司 170,270,659 股股份(占公司
                                              股份总数的 30.41%),同时通过持有公司第一大股东华厦医疗投资(厦门)
                                              有限公司 84%的股权控制公司 143,227,846 股股份(占公司股份总数的

                                              25.58%),苏庆灿通过直接或间接方式合计持有公司股份 313,498,505 股(占
                                              公司股份总数的 55.98%)。

                                              此外,苏世华与苏庆灿系兄妹关系,根据苏世华与苏庆灿签署的《一致行动
                                              协议》,苏世华作为苏庆灿
[点击查看PDF原文]